Site 100 — Louisville, Kentucky

Public research footprint of Site 100, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Autism · Asperger's Disorder · Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) · Head and Neck Squamous Cell Carcinoma

Recently updated registry entries

NCT06496178 — A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy… (Recruiting)
NCT05975905 — A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background… (Terminated)
NCT06347133 — Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Site 100?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.